Translational Control of Cancer: Implications for Targeted Therapy

作者: Peter B. Bitterman , Vitaly A. Polunovsky

DOI: 10.1007/978-1-60327-271-1_12

关键词:

摘要: The limitations of contemporary cytotoxic therapy and the unveiling signaling networks that govern decision a cancer cell to propagate or die have spawned era targeted anticancer therapy. However, treatment patients with agents targeting specific oncoproteins frequently leads acquired resistance. What is next step in therapy? One robust approach drug discovery might be target few key pathways activated by oncogenes at vulnerable steps, i.e., nodal points where oncogenic converge. This concept embraces unfortunate reality several hundred genetic alterations – no one which obligatory for carcinogenesis are able usurp critical regulatory hubs converting cells from normal malignant. It also powerfully motivates search those components cellular machinery ubiquitous absolutely essential parts circuitry yet resilient enough tolerate perturbation. Two decades experimental data summarized here indicate eIF4F mediating initiation translation mRNA into protein an hub multiple thus bona fide candidate molecular discovery.

参考文章(126)
Murty V. Chengalvala, Vargheese M. Chennathukuzhi, Daniel S. Johnston, Panayiotis E. Stevis, Gregory S. Kopf, Gene Expression Profiling and its Practice in Drug Development Current Genomics. ,vol. 8, pp. 262- 270 ,(2007) , 10.2174/138920207781386942
D S Askew, J L Cleveland, B C Simmons, R A Ashmun, Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. ,vol. 6, pp. 1915- 1922 ,(1991)
Nahum Sonenberg, Michael B. Mathews, John W. B. Hershey, Translational control in biology and medicine Cold Spring Harbor Laboratory Press. ,(2007)
Lynda Chin, Alice Tam, Jason Pomerantz, Michelle Wong, Jocelyn Holash, Nabeel Bardeesy, Qiong Shen, Ronan O'Hagan, Joe Pantginis, Hao Zhou, James W. Horner, Carlos Cordon-Cardo, George D. Yancopoulos, Ronald A. DePinho#, Essential role for oncogenic Ras in tumour maintenance Nature. ,vol. 400, pp. 468- 472 ,(1999) , 10.1038/22788
L Foulds, The experimental study of tumor progression: a review. Cancer Research. ,vol. 14, pp. 327- 339 ,(1954)
Bruce A. Chabner, Thomas G. Roberts, Chemotherapy and the war on cancer Nature Reviews Cancer. ,vol. 5, pp. 65- 72 ,(2005) , 10.1038/NRC1529
Yoshihiko Segawa, Yuji Heike, Ichiro Takata, Koichi Mandai, Toshiaki Hanafusa, Tasaburo Takasu, Nobuhiko Seki, Masao Nakata, Hideyuki Saeki, Kenji Eguchi, Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clinical Cancer Research. ,vol. 8, pp. 3046- 3053 ,(2002)
V A Polunovsky, I B Rosenwald, A T Tan, J White, L Chiang, N Sonenberg, P B Bitterman, Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Molecular and Cellular Biology. ,vol. 16, pp. 6573- 6581 ,(1996) , 10.1128/MCB.16.11.6573